Login / Signup

Undefeated-Changing the phenamacril scaffold is not enough to beat resistant Fusarium.

Rasmus D WollenbergSøren S DonauManuel H TaftZoltan BalázsSven GieseClaudia ThielJens L SørensenThorbjørn T NielsenHenriette GieseDietmar J MansteinReinhard WimmerTeis Esben Søndergaard
Published in: PloS one (2020)
Filamentous fungi belonging to the genus Fusarium are notorious plant-pathogens that infect, damage and contaminate a wide variety of important crops. Phenamacril is the first member of a novel class of single-site acting cyanoacrylate fungicides which has proven highly effective against important members of the genus Fusarium. However, the recent emergence of field-resistant strains exhibiting qualitative resistance poses a major obstacle for the continued use of phenamacril. In this study, we synthesized novel cyanoacrylate compounds based on the phenamacril-scaffold to test their growth-inhibitory potential against wild-type Fusarium and phenamacril-resistant strains. Our findings show that most chemical modifications to the phenamacril-scaffold are associated with almost complete loss of fungicidal activity and in vitro inhibition of myosin motor domain ATPase activity.
Keyphrases
  • wild type
  • escherichia coli
  • tissue engineering
  • systematic review
  • oxidative stress
  • multidrug resistant
  • gram negative
  • climate change
  • risk assessment